L. Roy Papp & Associates’s iShares Genomics Immunology and Healthcare ETF IDNA Stock Holding History

L. Roy Papp & Associates’s Portfolio IDNA Stock Details IDNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-15,555	Closed	-$362K	–	172
2023 Q1	$362K	Sell	15,555 -6,490	-29%	-$162K	0.05%	139
2022 Q4	$555K	Buy	22,045 +5,815	+36%	+$156K	0.08%	113
2022 Q3	$428K	Buy	+16,230	New	+$501K	0.06%	122

Other funds holding IDNA

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

WBG

Wharton Business Group Malvern, Pennsylvania $2.65B AUM 20.73% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

WAP

Wealthcare Advisory Partners West Chester, Pennsylvania $5.27B AUM 22.23% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

IWC

Integrated Wealth Concepts Waltham, Massachusetts $12.5B AUM 18.49% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

L. Roy Papp & Associates's IDNA Position: Q2 2023 in Review

L. Roy Papp & Associates sold out of iShares Genomics Immunology and Healthcare ETF (IDNA) in Q2 2023, closing a stake of 15,555 shares — an estimated $362K sold.

L. Roy Papp & Associates first reported a position in IDNA in Q3 2022 and held it in 3 quarters. The position peaked at $555K in Q4 2022. 67 funds tracked by Wall St. Rank hold IDNA as of Q2 2023.

L. Roy Papp & Associates reported no remaining iShares Genomics Immunology and Healthcare ETF position as of Q2 2023 after selling out during the quarter.
L. Roy Papp & Associates sold 15,555 iShares Genomics Immunology and Healthcare ETF shares in Q2 2023, an estimated $362K.
L. Roy Papp & Associates first reported a position in iShares Genomics Immunology and Healthcare ETF in Q3 2022 and held it in 3 quarters.
L. Roy Papp & Associates's iShares Genomics Immunology and Healthcare ETF position peaked at $555K in Q4 2022.
67 funds tracked by Wall St. Rank held iShares Genomics Immunology and Healthcare ETF as of Q2 2023.

Based on L. Roy Papp & Associates's 13F filing for Q2 2023, filed 17 Jul 2023.